Ingevity Corp Ownership

NGVT Stock  USD 44.25  0.35  0.80%   
The majority of Ingevity Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Ingevity Corp to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Ingevity Corp. Please pay attention to any change in the institutional holdings of Ingevity Corp as this could imply that something significant has changed or is about to change at the company.
 
Shares in Circulation  
First Issued
2014-09-30
Previous Quarter
36.3 M
Current Value
36.6 M
Avarage Shares Outstanding
40.5 M
Quarterly Volatility
2.3 M
 
Yuan Drop
 
Covid
Dividend Paid And Capex Coverage Ratio is likely to gain to 1.85 in 2025, whereas Dividends Paid is likely to drop slightly above 3.5 M in 2025. Common Stock Shares Outstanding is likely to drop to about 32.7 M in 2025. Net Income Applicable To Common Shares is likely to drop to about 150.9 M in 2025.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Ingevity Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Ingevity Stock please use our How to Invest in Ingevity Corp guide.

Ingevity Stock Ownership Analysis

About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.05. Ingevity Corp recorded a loss per share of 11.85. The entity had not issued any dividends in recent years. Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina. Ingevity Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 1850 people. To find out more about Ingevity Corp contact John Fortson at 843 740 2300 or learn more at https://www.ingevity.com.
Besides selling stocks to institutional investors, Ingevity Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ingevity Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ingevity Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Ingevity Corp Quarterly Liabilities And Stockholders Equity

2.02 Billion

Ingevity Corp Insider Trades History

Less than 1% of Ingevity Corp are currently held by insiders. Unlike Ingevity Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ingevity Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ingevity Corp's insider trades
 
Covid

Ingevity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ingevity Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ingevity Corp backward and forwards among themselves. Ingevity Corp's institutional investor refers to the entity that pools money to purchase Ingevity Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-12-31
814.5 K
Dimensional Fund Advisors, Inc.2024-12-31
793.4 K
Lsv Asset Management2024-12-31
762 K
Southernsun Asset Management, Llc2024-12-31
686.5 K
Inclusive Capital Partners Lp2024-09-30
667.9 K
Charles Schwab Investment Management Inc2024-12-31
646.3 K
Palisade Capital Management Llc2024-12-31
478.5 K
Morgan Stanley - Brokerage Accounts2024-12-31
448.5 K
Northern Trust Corp2024-12-31
438.7 K
Blackrock Inc2024-12-31
M
Vanguard Group Inc2024-12-31
4.2 M
Note, although Ingevity Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ingevity Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ingevity Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ingevity Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ingevity Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ingevity Corp Outstanding Bonds

Ingevity Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ingevity Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ingevity bonds can be classified according to their maturity, which is the date when Ingevity Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ingevity Corp Corporate Filings

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Ingevity Stock Analysis

When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.